SARS-CoV-2-IN-36
SARS-CoV-2-IN-36 is a potent SARS-CoV-2 Mpro (SARS-CoV) inhibitor with an IC50 of 2.37 μM and a Kd of 1.19 μM in enzymatic assays. SARS-CoV-2-IN-36 shows antiviral activity against UC-1074, RG2674, and NVDBB-2220 SARS-CoV-2 variants in Vero cells[1].
Product Specifications
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/sars-cov-2-in-36.html
Solubility
10 mM in DMSO
Smiles
[H]C(C(N[C@H](C(N[C@@H](CC1=CNC=N1)C=O)=O)CC2=CC=CC=C2)=O)N
Molecular Formula
C17H21N5O3
Molecular Weight
343.38
References & Citations
[1]Simone Di Micco, et al. Rational design of the zonulin inhibitor AT1001 derivatives as potential anti SARS-CoV-2. Eur J Med Chem. 2022 Dec 15;244:114857.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNCB2428-100 1x 100 µL
P63 (Squamous, Basal & Myoepithelial Cell Marker) (TP63/2428), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNUB2130-100 1x 100 µL
Cytokeratin 3 (KRT3) (Corneal Epithelial Marker) (KRT3/2130), 0.2mg/mL
Sign In for Pricing
View Details 
LY401968 100 µg
emopamil binding protein (EBP) (NM_006579) Human Over-expression Lysate
Sign In for Pricing
View Details 